Evidence map›Paper›PMID 41642436›Full record

SynthesisJournal of endocrinological investigation2026

Epidemiology of chronic hypoparathyroidism in Italy: a systematic review and meta-analysis.

T C M Topini, P Stagni, M Dobreva, C Galeone, C Cipriani, S Pirri, Maria Domenica Sanna

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Journal of endocrinological investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

T C M TopiniAscendis Pharma Bone Diseases, Hellerup, Denmark.
P StagniAscendis Pharma Bone Diseases, Hellerup, Denmark.
M DobrevaAscendis Pharma Bone Diseases, Hellerup, Denmark.
C GaleoneBicocca-Applied Statistics Center (B-ASC), Università degli Studi di Milano Bicocca, Milan, Italy.
C CiprianiDepartment of Medical and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.
S PirriRegulatory Pharma Net srl, Pisa, Italy.
Maria Domenica SannaRegulatory Pharma Net srl, Pisa, Italy. m.sanna@rpngroup.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeHypoparathyroidism (HPT) is an endocrine disease caused by insufficient levels of parathyroid hormone (PTH). PTH is the primary regulator of the calcium/phosphate balance, acting directly on bone and kidney, and indirectly on the intestine. Regarding the epidemiology of chronic HPT, there are limited data in Italy. This study aimed to establish incidence and prevalence of chronic HPT in Italy.

methodsA systematic literature review was conducted to identify the current knowledge regarding the epidemiology of chronic HPT in Italy, and a random effect meta-analysis was performed to estimate the pooled incidence. A subgroup analysis of non-surgical and postsurgical HPT estimates for patients was also conducted.

resultsWe identified 4 studies eligible for inclusion reporting data from 15,412 patients with HPT. Considering a thyroidectomy rate of 57 per 100,000 and the incidence of post-surgical chronic HPT (≥ 6 months after surgery) at 1.2% (95% CI: 0.7%-1.8%), the number of incident post-surgical chronic HPT was estimated in 353 cases. Based on a mean time with chronic HPT after diagnosis of 17.4 years, a total of 6,142 prevalent post-surgical chronic HPT patients has been estimated for Italy. Findings from this analysis showed 4,383 prevalent non-surgical chronic HPT cases in Italy. The prevalence of chronic HPT, both surgical and non-surgical, in the adult population in Italy has been estimated to be 10,524 cases.

conclusionThis study provides a current estimate of the prevalence and incidence of chronic HPT in Italy. In this analysis, postsurgical chronic HPT accounted for the majority of prevalent cases. Epidemiological studies with appropriate study design are necessary to provide a validated estimation of the prevalence and incidence of HPT in Italy.

Indexed as

HypoparathyroidismChronic DiseaseHumansIncidenceItalyPrevalenceEpidemiologyHPTIncidenceItalyPrevalence

Identifiers

PMID41642436
PMCPMC13219189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.